GLPwatch
Papers (10588)
Page 167 of 177, ranked by citation count.
- Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation.
- Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.
- Five-year follow-up of incretin-based therapy in a patient with KCNJ11-related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction.
- HMB and Liraglutide Confer Complementary Protection Against Lipotoxic and Atrophic Alterations in High-Glucose Plus Free Fatty Acid-Treated C2C12 Myotubes.
- Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.
- A commentary on 'Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial'.
- Glucagon-like peptide-1 receptor agonists and hair loss: A systematic review and meta-analysis.
- Effectiveness of GLP-1 Receptor Agonists in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
- Comparison table: Some FDA-approved drugs for weight management.
- Tirzepatide improves extracellular matrix integrity and vascularization in pancreatic islets of a mouse model of obesity, diabetes, and menopause.
- Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review.
- Retrospective Analysis of Hospitalized Patients with Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide 1 Receptor Agonist Therapy.
- MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism.
- The impact of adjuvant anti-obesity medications on 10-year weight loss outcomes after sleeve gastrectomy.
- [Victoza changes diabetes and lives of patients 5 years already].
- Pharmacological therapy in the obese patient: is it only a matter of fat loss?
- Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?
- Differential Acute Kidney Injury Profiles of GLP-1RAs and SGLT2is: A Network Meta-Analysis.
- Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.
- Lifestyle First and Lifestyle Always, Does Not Mean Lifestyle Only: Reimagining Cardiometabolic Care in the Era of GLP-1 Receptor Agonists.
- Structure-aware fragment assignment for interpreting tandem mass spectrometry of modified and cyclic peptides.
- GLP-1 Receptor Agonists for Treating Alcohol Use Disorder: A Critical Review.
- Tirzepatide improves neutrophilic inflammation in obese asthmatic mice by downregulating Th17 cell differentiation.
- Evidence-informed guidance for the clinical use of oral semaglutide in obesity management.
- GLP-1 receptor agonists and sexual function in women and men: a narrative review of emerging evidence and the need for further research.
- GLP-1 receptor agonist utilization is associated with a low risk of Anesthesia-related complications prior to total joint arthroplasty.
- Glycemic, renal, and graft outcomes with dulaglutide versus multiple daily insulin therapy after kidney transplantation in type 2 diabetes.
- The Preparation and Physicochemical Characterization of a Triple Synergistic Nanoplatform Designed for Targeted Subcutaneous Delivery of Sitagliptin with Potential for β-Cell Preservation.
- [Glucagon-like peptide-1 agonists and heart failure].
- Probable tirzepatide-associated limbic encephalitis with status epilepticus in a patient with extreme obesity: a case report.
- Glucagon-Like Peptide-1 Receptor Agonists Inhibit the Initiation of Toxic Amyloid-β42 Aggregation.
- Orforglipron Calcium.
- Tirzepatide.
- Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.
- Table: GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes.
- A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico.
- Decoding the hallmarks of GLP-1RA weight-loss super-responders.
- [A meta-analysis of efficacy and safety of anti-obesity medications in the treatment of childhood obesity].
- [Does liraglutide have a place in psychiatry ?]
- Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart.
- GLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies.
- Comparative Positioning of Orforglipron Among Selected GLP-1 Receptor Agonist Benchmarks: A Narrative Review.
- A Validated, Stability-Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance.
- An Ionic Liquid-Based Enteric Formulation for Enhanced Oral Delivery of Semaglutide in Type 2 Diabetes Mellitus.
- Tirzepatide improves angiogenesis after diabetic hindlimb ischemia through Akt/eNOS and ERK1/2 pathways.
- Assessment of Thermal and Photolytic Stress Effects on the Stability of Primary Structure of Synthetic Liraglutide Using LC-HRMS/MS.
- Bile acid diarrhoea.
- Efficacy and safety of pharmacological and non-pharmacological interventions for antipsychotic-induced weight gain in individuals with schizophrenia: A systematic review and network meta-analysis of 55 clinical trials.
- A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses.
- [Role of exendin-4 in cardiovascular diseases].
- In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 y.
- Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH.
- Study on chitosan/carrageenan core-shell nanoparticles for oral co-administration of insulin/exenatide enhance insulin secretion in type 2 diabetes.
- [GLP-1 agonist supports weight loss].
- Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide: a protocol for a randomised controlled trial in a single-centre setting.
- GLP-1 receptor agonist therapy in children and adolescents with obesity: A network meta-analysis of differential cardiometabolic efficacy and safety profiles.
- Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920.
- Is semaglutide a better weight-management option than bariatric surgery for patients undergoing total knee arthroplasty?
- Exenatide Reduces Graft Injury in a Rat Transplantation Model Using Kidneys Donated after Cardiac Death.
- [Pharmacological and clinical profiles of a human GLP-1 analogue, liraglutide (Victoza(®))].